To view the newsletter click here.

• Marina Massingham, CEO, Aifred Health, & Laurent Waessa, Sr. Business Development Advisor, Québec Government Office in New York, Virtually Visit BioTalk
• VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-19, 2021 (2)
• Digital Health Forum Presented by EAGB and BioHealth Innovation Registration, Thu, Mar 25, 2021 at 1:00 PM | Eventbrite
• Top 10 U.S. Biopharma Clusters (BHCR number 4 but metrics improved over 2020)
• Innovation Showcase - American College of Cardiology (April, 1)
• After merger, College Park startup IonQ plans to go public with $2 billion valuation
• VLP Therapeutics names seasoned biotech venture capitalist Miwa Toyoda as CBO | National News | kpvi.com
• Novavax Says Its COVID-19 Vaccine is 96% Efficacious | Time
• J&J plans to produce up to 3 billion doses of vaccine next year, United States News & Top Stories - The Straits Times
• Leveraging Artificial Intelligence in Human Health (Rich Bendis will Facilitate)
• Opinion | A Vaccine Maker’s Investment: Emergent BioSolutions Responds - The New York Times
• SPAC Alexandria Agtech/Climate Innovation Acquisition files for a $250 million IPO | Nasdaq
• Rockville-based Pediametrix receives $1M from National Science Foundation for R&D - Technical.ly DC
• Researchers in a Virginia Lab Lay Groundwork for U.S.-Made Drugs - Bloomberg
• Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA-Engineered Cell Therapy for Frontline Cancer · BioBuzz
• BioHealth Capital Region Women Making Waves in Venture Capital · BioBuzz
• 5 Questions with Destinie Burgan, Upstream Supervisor of Manufacturing, Emergent BioSolutions · BioBuzz
• Inova and University of Virginia School of Medicine open new campus | Headlines | insidenova.com
• Innovation alliance unveils new name and strategic plan for Western Virginia | Business Local | roanoke.com

To view the newsletter click here.